US Broker Ratings

Liquidia Corporation (LQDA) Stock Analysis: Exploring the 86.72% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company at the forefront of addressing unmet patient needs, has caught the attention of investors with its impressive 86.72% potential upside. Specializing in the..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Play with a 261.88% Potential Upside

Investors seeking opportunities in the healthcare sector might find PACS Group, Inc. (PACS) an intriguing proposition. Operating within the medical care facilities industry, PACS is renowned for its skilled nursing..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Unveiling a 68.47% Potential Upside in the Biotech Sector

For investors keen on the biotechnology sector, Tarsus Pharmaceuticals, Inc. (TARS) emerges as a notable contender with an attractive growth prospect. As a commercial-stage biopharmaceutical company, Tarsus is committed to..

MiMedx Group, Inc. (MDXG) Stock Analysis: Exploring an 87.79% Potential Upside in the Biotech Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology industry, stands out with a compelling 87.79% potential upside, according to analyst ratings. With a market capitalization hovering around..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a 173% Potential Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is capturing investor attention with its substantial potential upside. With an average target price of $55.00, analysts suggest a..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Innovator with 30.73% Upside Potential

Belite Bio, Inc (NASDAQ: BLTE) is catching the attention of investors with its promising advancements in the biotechnology sector, particularly in the field of retinal degenerative eye diseases. With a..

Centessa Pharmaceuticals (CNTA) Investor Outlook: A Biotech Gem with 134.9% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a healthcare innovator headquartered in the United Kingdom, stands out in the biotechnology sector with its promising clinical-stage pipeline and a remarkable potential upside. Despite..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Exploring a 39.24% Potential Upside in the Biotech Sector

Kymera Therapeutics, Inc. (NASDAQ: KYMR) emerges as a compelling player in the biotechnology sector, particularly for investors seeking exposure to innovative healthcare solutions. Founded in 2015 and headquartered in Watertown,..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Gem with 118% Upside Potential

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a key player in the biotechnology sector, is capturing attention with its innovative approach to severe allergic reactions. Headquartered in San Diego, California, this biopharmaceutical..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Unpacking the 57% Potential Upside

Amneal Pharmaceuticals, Inc. (AMRX) is catching the attention of investors with its noteworthy potential upside of 57.23%. As a prominent player in the healthcare sector, Amneal specializes in the development..

LivaNova PLC (LIVN): Investor Outlook Reveals 42% Potential Upside in Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector’s medical device industry, has recently garnered attention with its impressive potential upside of nearly 42%. Headquartered in London, this..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Exploring a 16.68% Upside Potential Backed by Robust Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a dynamic player in the healthcare sector, presents an intriguing opportunity for investors looking to tap into the biotechnology industry’s growth potential. With a market..

Clover Health Investments (CLOV): Analyst Ratings and 47.87% Potential Upside Signal Growth Potential

Clover Health Investments, Corp. (NASDAQ: CLOV) is steadily carving out a niche in the healthcare plans sector, leveraging its innovative platform, Clover Assistant, to transform the Medicare Advantage space. Based..

Artivion, Inc. (AORT) Stock Analysis: A Look at Its 12.62% Growth Potential

For investors seeking opportunities in the healthcare sector, Artivion, Inc. (NYSE: AORT) presents an intriguing proposition with an estimated 12.62% potential upside. With a market capitalization of $1.35 billion, this..

AdaptHealth Corp. (AHCO) Investor Outlook: Analyzing the 47% Potential Upside and Buy Ratings

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the U.S. healthcare sector, has garnered significant attention from investors, thanks to its robust projections and diverse service offerings in the medical..

Ascentage Pharma Group Internat (AAPG): Investor Outlook and Growth Potential with an 11% Upside

Ascentage Pharma Group International (AAPG), a burgeoning name in the biotechnology sector, is steadily capturing investor interest with its innovative approach to tackling some of the most challenging diseases, including..

89bio, Inc. (ETNB) Stock Analysis: Potential 191% Upside Captivates Investors

For investors with a keen eye on the biotechnology sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing opportunity. This clinical-stage biopharmaceutical company, which operates from its San Francisco headquarters, is..

SS Innovations International (SSII): A Rising Star in Healthcare Robotics with 40.8% Revenue Growth

SS Innovations International, Inc. (SSII), a pioneering entity in the healthcare sector, is making significant strides in the medical devices industry, specifically in the field of surgical robotics. Headquartered in..

Progyny, Inc. (PGNY) Stock Analysis: Uncovering a 20.97% Upside Potential in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) stands out as a key player in the healthcare sector, specifically in the healthcare plans industry. With its headquarters in New York, Progyny offers innovative fertility,..

Integra LifeSciences Holdings (IART) Stock Analysis: Navigating a 30.88% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a stalwart in the medical devices industry, presents a compelling narrative for investors intrigued by both challenges and opportunities within the healthcare sector. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds